DR.KARAN KUMAR
@karanbjmc93
Followers
276
Following
133
Media
4
Statuses
92
MD(Medicine), DM (Hepatology) Assistant Professor Hepatology & Liver Transplant. Mahatma Gandhi Medical College and Hospital.
Jaipur
Joined April 2012
RT @docMPK: Your personalized Share Link:.@ReibergerThomas.@BavenoCoop @AASLDtweets.@INASL_Liver. Thanks to Prof Dh….
thelancet.com
Recompensation of decompensated cirrhosis has been defined by the Baveno consensus as control or cure of the main underlying cause; resolution of clinical manifestations, including ascites and...
0
11
0
0
5
0
0
425
0
RT @ajay_duseja: Thanks EASL @EASLnews Dr Krag @AleksanderKrag Dr Shawcross @DebbieShawcros1 and the Governing Board of EASL for this recog….
0
15
0
RT @drkeithsiau: Now we have RCT evidence for tapered prednisolone dose for alcohol associated hepatitis - this significantly reduces infec….
0
50
0
RT @AnandVKulkarni2: "The important thing is not to stop questioning. Curiosity has its own reason for existing." – Albert Einstein.After f….
journals.lww.com
rimary objective was to assess the incidence of infection by day 90. The key secondary objectives were the incidence of mortality, acute kidney injury, readmissions rate, and adverse events. METHODS:...
0
41
0
RT @RoyAHep: 🔹Predicting non-response to Atezo/ Bev in u-HCC.Check out the HCC-AB .Multicentric Study from @AnandVKulkarni2 @ILBS_India @k….
0
4
0
RT @RoyAHep: 🔹How does CAP work as a tool for assessment of hepatic steatosis in LDLT donors ?.From @karanbjmc93 and team MGIMS. @INASL_L….
0
6
0
RT @drnipunverma: 🚨 Infections in ACLF: A Diagnostic challenge! 🔥. 👇 A study that taught collaboration, hardwork, mentorship, and never to….
0
32
0
RT @satenderpsingh: Predictors of non-response to Atezolizumab plus Bevacizumab in patients with unresectable Hepatocellular Carcinoma: A M….
0
14
0
RT @docMPK: Results of the STASH trial tapering steroids vs fixed steroids in AAH, lower risk of infection with similar mortality in either….
0
9
0
RT @AnandVKulkarni2: Thanks @juanpabloarab @karanbjmc93 @docMPK @giri_gutnliver for active participation. 🙏🏻.#livertwitter @AASLDtweets.
0
7
0
RT @ShivAroor: Have lost count of the number of sober non-religious people I know who gave up Deepavali crackers (for various reasons, incl….
0
3K
0
RT @AnandVKulkarni2: Do join us to know more about dosing regimen of pred in AAH on 18th afternoon (LB session) @AASLDtweets .@juanpabloara….
0
7
0
RT @AnandVKulkarni2: Mental well being is imp for patients with ACLF and DC. Now @HepCommJournal @ebtapper @juanpabloarab @docMPK @karanbj….
0
13
0
RT @RoyAHep: 🔸ALF in 🇮🇳has changed: HAV📈.🔸Differences in geographic distribution.🔸New data on both PLEX and CRRT.🔸Lactate Dynamics 👁️.1st M….
0
11
0
RT @BloomsburyIndia: Happy Publication Day to #OwnYourBody by Dr. Shiv Sareen ✨ .Divided into six clear & easy-to-follow sections focusing….
0
2
0
RT @docMPK: 📢Call for original articles for the special issue on Acute Liver Failure .Deadline 31st Jan 202.Please find the submission guid….
0
6
0
RT @AnandVKulkarni2: Use of alb in hospitalised patients is common. Is it harmful in those without AKI/SBP? .May be not. 20g/day x 3-4 da….
0
11
0